Vol 2007, No 89 (2007)

Table of Contents

Cartoons

Samples jpg
Business Review Editor

Deal Trackers

Letairis (ambrisentan) Abstract pdf
Business Review Editor

Features

BMS Enters the Biologics Acquisition Game Abstract pdf
Business Review Editor
Inverness' Spree Continues Abstract pdf
Business Review Editor
Royalty Rates in Pharmaceutical Licensing Deals Abstract pdf
Business Review Editor
Therapy Focus: Insomnia Abstract pdf
Business Review Editor

Licensing

Nycomed Gains Rights to NPS’ Gattex™ Abstract pdf
Business Review Editor
Synta’s GSK Deal No Investor Surprise Abstract pdf
Business Review Editor

General

Getting Real or Keeping It Real? Abstract
Business Review Editor
Avexa Ltd Abstract
Business Review Editor

Mergers & Acquisitions

Shire Divests Non-Essential Products Abstract pdf
Business Review Editor
AstraZeneca Gets Verus’ Asthma Assets Abstract pdf
Business Review Editor
Galenica Acquires Aspreva for US$915 M Abstract pdf
Business Review Editor

Business Commentaries

Passion and Determination are Success Drivers for Entrepreneurs Abstract html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.